Veronika A. Pavlova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Veronika A. Pavlova has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Viktor Robertovich Veber
Yaroslav-the-Wise Novgorod State University
3 shared publications - A. A. Pavlova2 shared publications
- Marina M. Mamontova
Yaroslav-the-Wise Novgorod State University
2 shared publications - Svetlana V. Zhmailova
Yaroslav-the-Wise Novgorod State University
2 shared publications Yaroslav-the-Wise Novgorod State University
2 shared publications- Irina V. Prozorova
Branch “Institute of Atomic Energy” of RSE National Nuclear Center of the Republic of Kazakhstan, Kurchatov, Kazakhstan
1 shared publication
Latest Publications
- 31 March 2026
- Published by ECO-Vector LLC (Publications) in HERALD of North-Western State Medical University named after I.I. Mechnikov
- Vol. 18 (1) , 61-70
Influence of sex, age, and female reproductive function on cardiac remodeling and the effects of renin-angiotensin-aldosterone system blockers
BACKGROUND: Arterial hypertension (AH) has gender and age-related features of its course, while current guidelines do not differentiate the therapeutic approach depending on these factors. The influence of sex and menopausal status on the effectiveness of renin-angiotensin-aldosterone system (RAAS) blockers in achieving regression of left ventricular (LV) remodeling has been insufficiently studied, which determines the relevance of the present study. AIM: To study the effect of RAAS-blocking drugs (the angiotensin-converting enzyme inhibitor perindopril and the angiotensin II receptor blocker valsartan) on LV remodeling parameters, renin and aldosterone levels in individuals of different ages, sexes, and also in postmenopausal women. METHODS: The study included 168 patients with grade 2 hypertension (60 men and 108 women, aged 25–70 years). An analysis of structural and geometric parameters of the LV (echocardiography) and concentrations of renin and aldosterone (enzyme immunoassay) was performed depending on sex, age, and the presence of postmenopause. The dynamics of the parameters were assessed after 6 months of therapy in patients who achieved target blood pressure while taking perindopril (4 mg/day) or valsartan (80 mg/day). RESULTS: In patients older than 60 years, a significant increase in left ventricular myocardial mass index (LVMMI) was revealed (p 0.05), predominantly in the hyperreninemic type of hypertension. In postmenopausal women, an increase in LVMMI, left ventricular relative wall thickness, and renin concentration was registered (p 0.05) compared with premenopausal women, while pathological types of remodeling reached 63.6%. During therapy, the greatest regression of left ventricular hypertrophy was observed in middle-aged patients and in those with an initially high renin level. In early postmenopause, valsartan demonstrated a statistically significant advantage over perindopril in reducing LVMMI (p = 0.028) and left ventricular relative wall thickness (p = 0.018), and also achieved normalization of renin levels in 100% of patients. CONCLUSION: Age and sex of patients with hypertension, as well as menopausal status in women, significantly affect the severity of LV remodeling. Therapy with RAAS blockers demonstrated the greatest efficacy in middle-aged patients and in those with the hyperreninemic type of hypertension, while in early postmenopause, valsartan has an advantage over perindopril in achieving regression of LV hypertrophy. A limitation of the study is the relatively short follow-up period (6 months) and the size of the subgroups for comparative analysis of the two drugs.
- 31 March 2026
- Published by ECO-Vector LLC (Publications) in HERALD of North-Western State Medical University named after I.I. Mechnikov
- Vol. 18 (1) , 61-70
Influence of sex, age, and female reproductive function on cardiac remodeling and the effects of renin-angiotensin-aldosterone system blockers
BACKGROUND: Arterial hypertension (AH) has gender and age-related features of its course, while current guidelines do not differentiate the therapeutic approach depending on these factors. The influence of sex and menopausal status on the effectiveness of renin-angiotensin-aldosterone system (RAAS) blockers in achieving regression of left ventricular (LV) remodeling has been insufficiently studied, which determines the relevance of the present study. AIM: To study the effect of RAAS-blocking drugs (the angiotensin-converting enzyme inhibitor perindopril and the angiotensin II receptor blocker valsartan) on LV remodeling parameters, renin and aldosterone levels in individuals of different ages, sexes, and also in postmenopausal women. METHODS: The study included 168 patients with grade 2 hypertension (60 men and 108 women, aged 25–70 years). An analysis of structural and geometric parameters of the LV (echocardiography) and concentrations of renin and aldosterone (enzyme immunoassay) was performed depending on sex, age, and the presence of postmenopause. The dynamics of the parameters were assessed after 6 months of therapy in patients who achieved target blood pressure while taking perindopril (4 mg/day) or valsartan (80 mg/day). RESULTS: In patients older than 60 years, a significant increase in left ventricular myocardial mass index (LVMMI) was revealed (p 0.05), predominantly in the hyperreninemic type of hypertension. In postmenopausal women, an increase in LVMMI, left ventricular relative wall thickness, and renin concentration was registered (p 0.05) compared with premenopausal women, while pathological types of remodeling reached 63.6%. During therapy, the greatest regression of left ventricular hypertrophy was observed in middle-aged patients and in those with an initially high renin level. In early postmenopause, valsartan demonstrated a statistically significant advantage over perindopril in reducing LVMMI (p = 0.028) and left ventricular relative wall thickness (p = 0.018), and also achieved normalization of renin levels in 100% of patients. CONCLUSION: Age and sex of patients with hypertension, as well as menopausal status in women, significantly affect the severity of LV remodeling. Therapy with RAAS blockers demonstrated the greatest efficacy in middle-aged patients and in those with the hyperreninemic type of hypertension, while in early postmenopause, valsartan has an advantage over perindopril in achieving regression of LV hypertrophy. A limitation of the study is the relatively short follow-up period (6 months) and the size of the subgroups for comparative analysis of the two drugs.
- 1 January 2025
- Published by Yaroslav-the-Wise Novgorod State University in Vestnik NovSU
- No. 2
Age-related changes in blood renin levels in healthy individuals and patients with arterial hypertension
The article presents the results of a study on the age-related dynamics of plasma renin levels in healthy individuals and patients with arterial hypertension, including both men and women in different age groups: young adults (25–44 years), middle-aged adults (45–59 years), and older adults (60 years and older). The study revealed the following pattern: with age, healthy men and women showed a progressive and significant decrease in plasma renin levels compared to the young adult group. In contrast, patients with arterial hypertension demonstrated a significant increase in renin levels with age. The age-related trend in plasma renin levels was similar in men and women but was more pronounced in men.
- 1 January 2025
- Published by Yaroslav-the-Wise Novgorod State University in Vestnik NovSU
- No. 2
Age-related changes in blood renin levels in healthy individuals and patients with arterial hypertension
The article presents the results of a study on the age-related dynamics of plasma renin levels in healthy individuals and patients with arterial hypertension, including both men and women in different age groups: young adults (25–44 years), middle-aged adults (45–59 years), and older adults (60 years and older). The study revealed the following pattern: with age, healthy men and women showed a progressive and significant decrease in plasma renin levels compared to the young adult group. In contrast, patients with arterial hypertension demonstrated a significant increase in renin levels with age. The age-related trend in plasma renin levels was similar in men and women but was more pronounced in men.
- 1 January 2024
- Published by Yaroslav-the-Wise Novgorod State University in Vestnik NovSU
- No. 2
DIAGNOSTIC SIGNIFICANCE OF LABORATORY STUDY OF RENIN LEVELS IN BLOOD IN PATIENTS WITH HYPERTENSION
The article presents the results of studying blood renin in arterial hypertension in men and women in two age groups: young and middle-aged. Renin was determined by examination of venous blood by enzymelinked immunosorbent assay. In a study of a group of 80 patients: 40 women and 40 men, it was found that the normorenin type of arterial hypertension predominates at young age: 95% in men and 90% in women. In the course of the study, the following feature was revealed: the incidence of high-renin arterial hypertension increases with age. In middle-aged men, high-renin arterial hypertension predominates (55%), while in middleaged women, the normorenin type of arterial hypertension predominates (60%).
- 1 January 2024
- Published by Yaroslav-the-Wise Novgorod State University in Vestnik NovSU
- No. 2
DIAGNOSTIC SIGNIFICANCE OF LABORATORY STUDY OF RENIN LEVELS IN BLOOD IN PATIENTS WITH HYPERTENSION
The article presents the results of studying blood renin in arterial hypertension in men and women in two age groups: young and middle-aged. Renin was determined by examination of venous blood by enzymelinked immunosorbent assay. In a study of a group of 80 patients: 40 women and 40 men, it was found that the normorenin type of arterial hypertension predominates at young age: 95% in men and 90% in women. In the course of the study, the following feature was revealed: the incidence of high-renin arterial hypertension increases with age. In middle-aged men, high-renin arterial hypertension predominates (55%), while in middleaged women, the normorenin type of arterial hypertension predominates (60%).